Clinical Trials
3 trialsNCT02608268 2023-12-06
Phase I-Ib/II Study of MBG453 as Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies
Novartis
Phase 1/2 Terminated
NCT04049344 2019-08-08
Decitabine Combined With Oxaliplatin in Patients With Advanced Renal Cell Carcinoma
Zhejiang Cancer Hospital
Phase 2 Unknown
NCT00561912 2011-12-26
Low Dose Decitabine + Interferon Alfa-2b in Advanced Renal Cell Carcinoma
M.D. Anderson Cancer Center
Phase 2 Terminated